Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 34 min ago
Peer-reviewedLicence not statedClinical Microbiology and Infection

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status

  • S. Servais
  • N. Dumontier
  • L. Biard
  • N. Schnepf
  • M. Resche-Rigon
  • R. Peffault de Latour
  • C. Scieux
  • M. Robin
  • M. Meunier
  • A. Xhaard
  • F. Sicre de Fontbrune
  • J. Le Goff
3 more authors
  • G. Socié
  • F. Simon
  • M.-C. Mazeron
Open at sourcePDFDOICite

Related

  1. Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Cytomegalovirus: Updated Approach to Management for Kidney Transplant Recipients
    Sahrish Ilyas, Emily A. Blumberg
    Kidney International ReportsPeer-reviewedCC BY-NC-ND 4.0Full text1 citedEpidemiology & public healthPMCEurope PMC
  3. Maribavir in lung transplant recipients with cytomegalovirus infection: real-life experience
    Tobias Veit, Stefan Trost, Teresa Kauke +9
    InfectionPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  4. Immunogenicity of sequential conjugate and non-conjugate pneumococcal vaccination in dialysis patients and kidney transplant recipients: a 12-month serological follow-up
    Sophie Novelli, Aimé Nun, Antoine Cases +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  5. An Active Cytomegalovirus Infection and Epstein-Barr Virus Reactivation Complicated by Cytomegalovirus Meningitis and Virus-Associated Hemophagocytic Lymphohistiocytosis during Methotrexate and Upadacitinib Therapy in a Patient with Rheumatoid Arthritis
    Kazuki Tomiyama, Soma Fukami, Toshitaka Yukishima +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{servais2026response,
  title = {{Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status}},
  author = {S. Servais and N. Dumontier and L. Biard and N. Schnepf and M. Resche-Rigon and R. Peffault de Latour and C. Scieux and M. Robin and M. Meunier and A. Xhaard and F. Sicre de Fontbrune and J. Le Goff and G. Socié and F. Simon and M.-C. Mazeron},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  month = oct,
  doi = {10.1016/j.cmi.2015.11.006},
  url = {https://hal.science/hal-05783501v1},
}
RIS
TY  - JOUR
TI  - Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
AU  - S. Servais
AU  - N. Dumontier
AU  - L. Biard
AU  - N. Schnepf
AU  - M. Resche-Rigon
AU  - R. Peffault de Latour
AU  - C. Scieux
AU  - M. Robin
AU  - M. Meunier
AU  - A. Xhaard
AU  - F. Sicre de Fontbrune
AU  - J. Le Goff
AU  - G. Socié
AU  - F. Simon
AU  - M.-C. Mazeron
PY  - 2026
DA  - 2026/10/07
JO  - Clinical Microbiology and Infection
DO  - 10.1016/j.cmi.2015.11.006
UR  - https://hal.science/hal-05783501v1
SN  - 1198-743X
SN  - 1469-0691
ER  -